Itron (ITRI) director granted 555 deferred shares in Form 4/A filing
Rhea-AI Filing Summary
Itron, Inc. reported an amended insider transaction for a board member on a Form 4/A. On 01/02/2026, an independent director received a grant of 555 shares of common stock as part of the quarterly stock compensation for serving on the board. The filing notes these shares were deferred under Itron's Executive Deferred Compensation Plan rather than received immediately. Following this grant, the director beneficially owned 21,917 Itron shares. The amendment clarifies that 26 shares had previously been omitted due to an arithmetic error.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Itron (ITRI) disclose in this Form 4/A?
Itron disclosed that an independent director received a grant of 555 shares of common stock on 01/02/2026 as part of quarterly board compensation.
Why was this Itron (ITRI) Form 4/A filed as an amendment?
The Form 4/A was filed to correct an error and include 26 shares that were inadvertently omitted due to an arithmetic error in the prior report.
How many Itron (ITRI) shares does the director own after this transaction?
After the reported transaction, the director beneficially owned 21,917 shares of Itron common stock.
Was cash paid for the Itron (ITRI) shares granted to the director?
No cash was paid; the 555 shares were granted at a price of $0 as stock compensation for board service.
How were the granted Itron (ITRI) shares treated for the director?
The filing states that the director deferred receipt of the 555 shares under Itron's Executive Deferred Compensation Plan.
What is the director’s relationship to Itron (ITRI)?
The reporting person is identified as a director of Itron, Inc. and is not listed as a 10% owner or officer in this filing.